Citations for
1MSLN, MUC16
Coexpression of MUC16 and mesothelin is related to the invasion process in pancreatic ductal adenocarcinoma.
Shimizu A, Hirono S, Tani M, Kawai M, Okada K, Miyazawa M, Kitahata Y, Nakamura Y, Noda T, Yokoyama S, Yamaue H.
Cancer Sci 103(4):739-46. doi: 10.1111/j.1349-7006.2012.02214.x. Epub 2012 Feb 23. 2012
2MSLN
Mesothelin promotes invasion and metastasis in breast cancer cells.
Wang Y, Wang L, Li D, Wang HB, Chen QF.
J Int Med Res 40(6):2109-16. 2012
3MMP7, MSLN
Mesothelin enhances invasion of ovarian cancer by inducing MMP-7 through MAPK/ERK and JNK pathways.
Chang MC, Chen CA, Chen PJ, Chiang YC, Chen YL, Mao TL, Lin HW, Lin Chiang WH, Cheng WF.
Biochem J 442(2):293-302. doi: 10.1042/BJ20110282. 2012
4MSLN
Exon deletion in the MSLN gene encoding MPF/mesothelin precursor protein during Laurasiatherian mammal evolution.
Kim DS, Hahn Y.
Int J Mol Med 27(2):289-93. doi: 10.3892/ijmm.2010.573. Epub 2010 Dec 2. 2011
5MSLN
Mesothelin (MSLN) promoter is hypomethylated in malignant mesothelioma, but its expression is not associated with methylation status of the promoter.
Tan K, Kajino K, Momose S, Masaoka A, Sasahara K, Shiomi K, Izumi H, Abe M, Ohtsuji N, Wang T, Hino O, Fujii H.
Hum Pathol 41(9):1330-8. doi: 10.1016/j.humpath.2010.03.002. Epub 2010 Jun 22. 2010
6MSLN, MUC16
A binding domain on mesothelin for CA125/MUC16.
Kaneko O, Gong L, Zhang J, Hansen JK, Hassan R, Lee B, Ho M.
J Biol Chem. 6;284(6):3739-49 2009
7MSLN, MUC16
A binding domain on mesothelin for CA125/MUC16.
Kaneko O, Gong L, Zhang J, Hansen JK, Hassan R, Lee B, Ho M.
J Biol Chem 284(6):3739-49. doi: 10.1074/jbc.M806776200. Epub 2008 Dec 15. 2009
8MSLN
Mesothelin-induced pancreatic cancer cell proliferation involves alteration of cyclin E via activation of signal transducer and activator of transcription protein 3.
Bharadwaj U, Li M, Chen C, Yao Q.
Mol Cancer Res 6(11):1755-65. doi: 10.1158/1541-7786.MCR-08-0095. 2008
9MSLN
Mesothelin promotes anchorage-independent growth and prevents anoikis via extracellular signal-regulated kinase signaling pathway in human breast cancer cells.
Uehara N, Matsuoka Y, Tsubura A.
Mol Cancer Res 6(2):186-93. doi: 10.1158/1541-7786.MCR-07-0254. Epub 2008 Feb 1. 2008
10MSLN
Mesothelin is not required for normal mouse development or reproduction
Bera, T. K.; Pastan, I.
Mol Cell Biol. 20: 2902-2906 2000
11MSLN
Soluble member(s) of the mesothelin/megakaryocyte potentiating factor family are detectable in sera from patients with ovarian carcinoma.
Scholler N, et al.
Proc Natl Acad Sci U S A 96(20):11531-6 1999
12MSLN
Cloning and expression of the recombinant FAb fragment of monoclonal antibody K1 that reacts with mesothelin present on mesotheliomas and ovarian cancers.
Brinkmann U, Webber K, Di Carlo A, Beers R, Chowdhury P, Chang K, Chaudhary V, Gallo M, Pastan I.
Int J Cancer. 71(4):638-44 1997
13MSLN
Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers.
Chang K, et al.
Proc Natl Acad Sci U S A 93(1):136-40 1996
14MSLN
Molecular cloning and expression of megakaryocyte potentiating factor cDNA.
Kojima T, et al.
J Biol Chem 270(37):21984-90 1995